InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by HAMILTON JOHN F, Director. Director active across 1 companies, notably Aridis Pharmaceuticals, Inc.. In total, 2 reports have been logged. Total volume traded: €16k. The latest transaction was filed on 27 July 2021 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations2 total
€8,2382,000 shares@ €4.119100.0% of flow
Common Stock
SEC:0001104659-21-096534·
Ideal exit: 23 Apr 2022 (T+270)
€8,2382,000 shares@ €4.1190.027% mcap50.0% of flow
Common Stock
SEC:0001104659-21-096534:0·
Ideal exit: 23 Apr 2022 (T+270)
2 of 2 declarations
About HAMILTON JOHN F
John F. Hamilton is a Board Member at Aridis Pharmaceuticals, Inc. He brings his expertise in corporate governance and strategy to the management team. Hamilton is involved in key decisions regarding product development and the strategic direction of the company. His experience in the pharmaceutical sector is a valuable asset for Aridis.
